Circulating levels of liver-enriched antimicrobial peptide 2 (LEAP2), a ghrelin receptor antagonist, decrease under caloric restriction and increase in obesity. The gene discussed is LEAP2; the disease is obesity due to melanocortin 4 receptor deficiency.